MENU MENU

Explore Deeply. Uncover the Possibilities.

Pioneering innovative therapeutic options
for patients who need them the most.

Learn More

Illuminating Possibilities. Charting Pathways.

Pioneering innovative therapeutic options
for patients who need them the most.

Learn More

Expanding Possibilities.Building Hope.

Pioneering innovative therapeutic options
for patients who need them the most.

Learn More

We create first-in-class medicines to treat chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, and pancreatic cancer.

Pipeline

We are developing products with the potential to change lives.

Clinical Trials

We are dedicated to responsibly developing groundbreaking therapies for serious and life-threatening diseases.

FibroGen China

We have taken an unprecedented approach to introducing world-class innovations in China.

Press Releases

Roxadustat Approved in China for Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis

FibroGen Reports Second Quarter 2019 Financial Results

FibroGen to Report Second Quarter 2019 Financial Results on Thursday, August 8, 2019

The New England Journal of Medicine (NEJM) Publishes Roxadustat China Phase 3 Results for the Treatment of Anemia in Chronic Kidney Disease Patients Receiving Dialysis

Roxadustat China Phase 3 Trial for Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine (NEJM)
View All

FG Culture

“Being surrounded by so many intelligent, kind, and professional people makes FibroGen a wonderful place to work.”

David Gervasi
Associate Scientist II, Cell Biology

Contact Our Company

We are growing a dedicated team committed to innovation and helping patients worldwide.

Contact Us